Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

13.44

+0.13 (0.98%)

At close: Aug 7, 2026, 4:00 PM EDT

13.25

-0.19 (-1.41%)

After-hours: Aug 7, 2026, 7:59 PM EDT

Tenax Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	117.98	97.57	94.85	9.79	2.12	5.58
Cash & Short-Term Investments	117.98	97.57	94.85	9.79	2.12	5.58
Cash Growth	11.87%	2.86%	868.66%	361.09%	-61.97%	-16.82%
Other Current Assets	3.69	6.66	1.84	1.89	1.08	0.11
Total Current Assets	121.66	104.23	96.69	11.68	3.21	5.69
Net Property, Plant & Equipment	-	-	-	-	0.19	0.29
Other Long-Term Assets	-	-	-	0	0.01	0.01
Total Assets	121.66	104.23	96.69	11.69	3.4	5.99
Accounts Payable	6.8	6.04	3.16	2.07	0.45	0.86
Accrued Expenses	1.28	1.12	1.54	1.01	0.78	0.7
Current Portion of Long-Term Debt	-	-	-	0.5	0.62	-
Total Current Liabilities	8.07	7.16	4.69	3.59	1.85	1.56
Long-Term Leases	-	-	-	-	0.06	0.18
Total Long-Term Liabilities	-	-	-	-	0.06	0.18
Total Liabilities	8.07	7.16	4.69	3.59	1.91	1.75
Common Stock	-	0	-	-	0	0
Additional Paid-in Capital	-	464.52	406.85	305.35	291.03	282.74
Retained Earnings	-400.97	-367.45	-314.86	-297.25	-289.54	-278.49
Shareholders' Equity	113.59	97.07	91.99	8.1	1.49	4.24
Total Liabilities & Equity	121.66	104.23	96.69	11.69	3.4	5.99
Total Debt	-	0	0	0.5	0.69	0.18
Net Cash (Debt)	117.98	97.57	94.85	9.29	1.44	5.4
Net Cash Growth	11.87%	2.86%	920.89%	547.37%	-73.42%	-16.51%
Net Cash Per Share	2.67	2.49	6.21	37.40	11.08	41.68
Book Value	113.59	97.07	91.99	8.1	1.49	4.24
Book Value Per Share	2.57	2.48	6.02	32.59	11.52	32.76
Tangible Book Value	113.59	97.07	91.99	8.1	1.49	4.24
Tangible Book Value Per Share	2.57	2.48	6.02	32.59	11.52	32.76

SEC Filings: 10-K · 10-Q